Techub News reports that MEI Pharma, a publicly listed company in the U.S. stock market, has committed to invest over 100 million USD to establish a Litecoin (LTC) reserve under the leadership of Titan Partners Group and the cryptocurrency investment firm GSR. GSR will serve as the strategic advisor and digital asset financial manager for the company, and Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.

LTC3.83%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin